Composition
- Active ingredients
- BENDAMUSTINE HYDROCHLORIDE 100MG/4ML (25MG/ML)
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application NDA205580.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Belrapzo
- Active substance
- bendamustine hydrochloride
- Route
- Intravenous
- Dosage form
- Solution
- Applicant
- Eagle Pharms
- Status
- Prescription
- FDA approval
- 15 May 2018
- Application
- NDA205580-001